Dirk Pleimes
CEO PentixaPharm GmbH
Seminars
Tuesday 21st July 2026
Fireside Chat: What I Wish I Knew When Entering Radiopharma
2:30 pm
Thinking about entering radiopharma – or wish you’d known more before you did? Join seasoned leaders from R&D, CMC, clinical, and commercial as they share hard-won lessons, practical pitfalls, and insider insights across the entire development journey, and bring your questions to those who’ve navigated it firsthand.
- R&D and Preclinical: novel target choices, targeting molecules, linkers, chelators, preclinical dosimetry and more
- CMC and Regulatory: isotope properties, differences in supply chain, logistics networks, CMC innovations, regulatory considerations and more
- Clinical Development: clinical trial design, working with sites, working with clinical stakeholders, patient centric approaches and more
Thursday 23rd July 2026
Conducting a Phase Zero Study to Examine Hematologic Toxicities & Understand Dose-Limiting Effects & Mechanistic Uncertainty caused by Bystander Irradiation
11:30 am
- Characterizing early hematologic effects and dose-limiting toxicities using Phase 0 microdosing studies
- Dissecting mechanisms of bystander irradiation contributing to bone marrow exposure and cytopenias
- Informing dose escalation and safety margins for subsequent first-in-human and Phase 1 trials
